Inventor · disambiguated record
Jiquan Zhang
Also filed as: ZHANG JIQUAN
9 granted patents·7 pending applications·190 citations·filing 2012–2025
86Inventor score
Files withNOVARTIS AG13BROGDON JENNIFER1JIUHUA HUAYUAN PHARMACEUTICAL CO LTD1SUNSHINE LAKE PHARMA CO LTD1
Top patents by PatentIndex Score
16 records- 0197US9815901B2Treatment of cancer using a CD123 chimeric antigen receptorBROGDON JENNIFER·Filed 2015·Granted Nov 14, 2017·94 cites·40 claims
- 0297US9777061B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Oct 3, 2017·85 cites·24 claims
- 0385US10568947B2Treatment of cancer using a CLL-1 chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Feb 25, 2020·6 cites·38 claims
- 0483US10703819B2Treatment of cancer using a CD123 chimeric antigen receptorNOVARTIS AG·Filed 2017·Granted Jul 7, 2020·1 cites·33 claims
- 0582US10851166B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2017·Granted Dec 1, 2020·1 cites·22 claims
- 0679US2023220090A1Treatment of cancer using a cd123 chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0779US2025353916A1Treatment of cancer using a cd33 chimeric antigen receptorNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0876US9181277B2Aminoquinazoline derivatives and their salts and methods of useSUNSHINE LAKE PHARMA CO LTD·Filed 2012·Granted Nov 10, 2015·3 cites·8 claims
- 0970US11591404B2Treatment of cancer using a CD123 chimeric antigen receptorNOVARTIS AG·Filed 2020·Granted Feb 28, 2023·0 cites·33 claims
- 1070US2023052970A1Phosphoglycerate kinase 1 (pgk) promoters and methods of use for expressing chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1169US12338287B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2020·Granted Jun 24, 2025·0 cites·24 claims
- 1265US2020215171A1Treatment of cancer using a cll-1 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1354US11459390B2Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptorNOVARTIS AG·Filed 2016·Granted Oct 4, 2022·0 cites·21 claims
- 1453US2025161392A1Traditional chinese medicine composition for treating pediatric exogenous wind-heat and preparation thereforJIUHUA HUAYUAN PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1545US2023037682A1Binding molecules against cd3 and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1639US2021198368A1Multispecific molecules targeting cll-1NOVARTIS AG·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →